The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Dementia prevention in memory clinics: recommendations from the European task force for brain health services
Open accessAbstract
Observational population studies indicate that prevention of dementia and cognitive decline is being accomplished, possibly as an unintended result of better vascular prevention and healthier lifestyles. Population aging in the coming decades requires deliberate efforts to further decrease its prevalence and societal burden. Increasing evidence supports the efficacy of preventive interventions on persons with intact cognition and high dementia risk. We report recommendations for the deployment of second-generation memory clinics (Brain Health Services) whose mission is evidence-based and ethical dementia prevention in at-risk individuals. The cornerstone interventions consist of (i) assessment of genetic and potentially modifiable risk factors including brain pathology, and risk stratification, (ii) risk communication with ad-hoc protocols, (iii) risk reduction with multi-domain interventions, and (iv) cognitive enhancement with cognitive and physical training. A roadmap is proposed for concept validation and ensuing clinical deployment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
Self-citationRetractedNgandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689
Self-citationDonanemab in Early Alzheimer’s Disease
Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100708 · Cited by 1,728
Williamson (2019) · doi:10.1001/jama.2018.21442 · Cited by 1,246
Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group
Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00066-1 · Cited by 1,051 · cited 1×
“25 All risk factors are reported in Table 2 and categorized into genetic, potentially modi fi able without measured brain pathology (in early life, midlife, and late life), and potentially modi fi able of brain pathology.”
BackgroundSelf-citationGlobal estimates on the number of persons across the Alzheimer's disease continuum
Gustavsson, A., Norton, N., Fast, T., Frölich, L., Georges, J., Holzapfel, D., Kirabali, T., Krolak‐Salmon, P., Rossini, P. M., Ferretti, M. T., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12694 · Cited by 895
Self-citationSwanson, C. J., Zhang, Y., Dhadda, S., Wang, J., Kaplow, J., Lai, R. Y. K., Lannfelt, L., Bradley, H., Rabe, M., Koyama, A., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00813-8 · Cited by 847
Alzheimer’s disease drug development pipeline: 2021
Cummings, J., Lee, G., Zhong, K., Fonseca, J., & Taghva, K. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12179 · Cited by 539 · cited 1×
“…interventions (e.g. probiotics and microbiome-based drugs, metabolism and bioenergetics, photo-oxygenation, SV2A modulators, active on mitochondrial stress, transfusion with young blood, among others) 60,61 will need to show ef fi cacy at reducing the risk for cognitive impairment and dementia.”
BackgroundSelf-citationResponsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps
Polygenic Risk Score Task Force of the International Common Disease Alliance, Adeyemo, A., Balaconis, M. K., Darnes, D. R., Fatumo, S., Granados Moreno, P., Hodonsky, C. J., Inouye, M., Kanai, M., Kato, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01549-6 · Cited by 413
Functional cognitive disorders: a systematic review
McWhirter, L., Ritchie, C., Stone, J., & Carson, A. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30405-5 · Cited by 240 · cited 1×
“51 Others may have potentially treatable conditions such as mental distress, polypharmacy, intracranial mass, perimeno-pause, suboptimal sleep or sleep-apnea syndrome.”
BackgroundSelf-citation
Cited by
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
Dubois, B., Villain, N., Schneider, L., Fox, N., Campbell, N., Galasko, D., Kivipelto, M., Jessen, F., Hanseeuw, B., Boada, M., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.3770 · Cited by 426
Self-citationNew landscape of the diagnosis of Alzheimer’s disease
Frisoni, G. B., Hansson, O., Nichols, E., Garibotto, V., Schindler, S. E., van der Flier, W. M., Jessen, F., Villain, N., Arenaza-Urquijo, E. M., Crivelli, L., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01294-2 · Cited by 143
Self-citationOnce upon a time, the Amyloid Cascade Hypothesis
Granzotto, A., & Sensi, S. L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102161 · Cited by 57
“A favorable but unexpected decrease is likely explained by profound societal changes that shape the risk of developing dementia and disclose easily targetable modifiable factors (Livingston et al., 2020; Frisoni et al., 2023).”
BackgroundExercise-related physical activity relates to brain volumes in 10,125 individuals
Raji, C. A., Meysami, S., Hashemi, S., Garg, S., Akbari, N., Ahmed, G., Chodakiewitz, Y. G., Nguyen, T. D., Niotis, K., Merrill, D. A., et al. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-230740 · Cited by 48
Cabreira, V., Alty, J., Antic, S., Araújo, R., Aybek, S., Ball, H. A., Baslet, G., Bhome, R., Coebergh, J., Dubois, B., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.16318 · Cited by 24
“This comes at a time when models of brain health clinics are being discussed to replace traditional cognitive clinics focused on a neurodegenerative paradigm and to incorporate the new complementary tools and biomarkers in the diagnosis of neurocognitive disorders [23, 24].”
Self-citation
Metadata
- Authors
- Frisoni, G. B., Altomare, D., Ribaldi, F., Villain, N., Brayne, C., Mukadam, N., Abramowicz, M., Barkhof, F., Berthier, M., Bieler-Aeschlimann, M., Blennow, K., Brioschi Guevara, A., Carrera, E., Chételat, G., Csajka, C., Demonet, J.-F., Dodich, A., Garibotto, V., Georges, J., Hurst, S., Jessen, F., Kivipelto, M., Llewellyn, D. J., McWhirter, L., Milne, R., Minguillón, C., Miniussi, C., Molinuevo, J. L., Nilsson, P. M., Noyce, A., Ranson, J. M., Grau-Rivera, O., Schott, J. M., Solomon, A., Stephen, R., van der Flier, W., van Duijn, C., Vellas, B., Visser, L. N. C., Cummings, J. L., Scheltens, P., Ritchie, C., & Dubois, B.
- Venue
- The Lancet Regional Health - Europe
- Publisher
- Elsevier BV
- Published
- 2023-03
- Volume
- 26
- Pages
- 100576
- ISSN
- 2666-7762 (ISSN-L)
- OpenAlex
- W4318716385
- Cited by
- 186
- References
- 18
- FWCI
- 33.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dementia prevention in memory clinics: recommendations from the European task force for brain health services. https://app.cochat.ai/papers/10.1016/j.lanepe.2022.100576
- The paper
- Frisoni, G. B., Altomare, D., Ribaldi, F., Villain, N., Brayne, C., Mukadam, N., Abramowicz, M., Barkhof, F., Berthier, M., Bieler-Aeschlimann, M., Blennow, K., Brioschi Guevara, A., Carrera, E., Chételat, G., Csajka, C., Demonet, J.-F., Dodich, A., Garibotto, V., Georges, J., . . . Dubois, B. (2023). Dementia prevention in memory clinics: recommendations from the European task force for brain health services. The Lancet Regional Health - Europe. https://doi.org/10.1016/j.lanepe.2022.100576
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.